Iron deposition in the anterior pituitary in homozygous beta- thalassemia: MRI evaluation and correlation with gonadal function

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 2, 2000, Pages 179-184

  Berkovitch, M ^a   Bistritzer, Tzvy ^a,d   Milone, S D ^b   Perlman, K ^b   Kucharczyk, W ^c   Koren, G ^b   Olivieri, N F ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Beta thalassemia; Deferoxamine; Gonadal function; Iron; MRI; Puberty

Indexed keywords

DEFEROXAMINE; IRON;

ADENOHYPOPHYSIS; ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; ENDOCRINE FUNCTION; FEMALE; GONAD FUNCTION; HUMAN; HYPOPHYSIS FUNCTION; IRON OVERLOAD; IRON STORAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROVOCATION TEST; PUBERTY;

EID: 0034047564     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.2.179     Document Type: Article

References (28)

1. Wolfe LC, Olivieri NF, Sallan D, Colan S, Rose V, Propper R, Freedman MH, Nathan DG. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med 1985; 312: 1600-1603.
2. Weatherall DJ, Pippard MJ, Callender ST Iron loading in thalassemia - five years with the pump. N Engl J Med 1983; 308: 456-458.
3. Cohen AR. Iron overload in the pediatric patient. In: Oski FA, ed. Hematology/Oncology Clinics of North America. Philadelphia, PA: WB Saunders, 1987; 521-544.
4. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland J. Effect of age at the start of iron chelation therapy on gonadal function in beta thalassemia major. N Engl J Med 1990; 323: 713-719.
5. Borgna-Pignatti C, De Stefano P, Zonta L, Vullo C, De Sanctis V, Melevendi C, Naselli A, Masera G, Terzoli S, Gabutti V, Piga A. Growth and sexual maturation in thalassemia major. J Pediatr 1985; 106: 150-155.
6. Kletzky OA, Costin G, Marrs RP, Bernstein G, March CM, Mishell DR. Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab 1979; 48: 901-905.
7. De Sanctis V, Vullo C, Katz M, Wonke B, Tamas R, Bagni B. Gonadal function in patients with beta thalassemi major. J Clin Pathol 1988; 41: 133-147.
8. Kelly TM, Edwards C, Meikle AW, Kushner JP. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med 1984; 101: 629-632.
9. Siemons LJ, Mahler CH. Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J Clin Endocrinol Metab 1987; 65: 535-537.
10. Fujisawa I, Morikawa M, Nakano Y, Komishi J. Hemochromatosis of the pituitary gland: MR imaging. Radiology 1988; 168: 213-214.
11. Stark DD, Moseley ME, Bacon BR, Moss AA, Goldberg HI, Bass NM, James TL. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154: 137-142.
12. Brittenham GM, Farrel DE, Harris JW, Feldman EF, Danish EH, Angus Muir W, Tripp JH, Bellon EM. Magnetic-susceptibility measurement of human iron stores. N Engl J Med 1982; 307: 1671-1675.
13. Wollesen F, Swerdloff RS, Odell WD. LH and FSH responses to luteinizing releasing hormone in normal fertile women. Metabolism 1976; 25: 1275-1285.
14. Wollesen F, Swerdloff RS, Odell WD. LH and FSH responses to luteinizing-releasing hormone in normal, adult, human males. Metabolism 1976; 25: 845-863.
15. Zachmann M, Prader A, Kind HP, Haflinger H, Budlinger H. Testicular volume during adolescence: cross-sectional and longitudinal studies. Helv Paediatr Acta 1974; 29: 61-72.
16. Tanner JM. Growth at Adolescence, 2nd Ed. Oxford: Blackwell Scientific, 1962; 33.
17. Kuo B, Zaino E, Roginsky MS. Endocrine function in thalassemia major. J Clin Endocrinol 1968; 28: 805-808.
18. Jacobs A. Metabolic consequences of iron overload. Br J Haematol 1976; 34: 1-4.
19. McIntosh N. Endocrinopathy in thalassemia major. Arch Dis Child 1976; 51: 195-201.
20. Modell B. Total management of thalassemia major. Arch Dis Child 1977; 52: 489-500.
21. Costin G, Kogut MD, Hyman CB, Ortega JA. Endocrine abnormalities in thalassemia major. Am J Dis Child 1979; 133: 497-502.
22. Livadas DP, Sofroniadou K, Souvatzogtlou A, Boukis M, Siafaka L, Koutras DA. Pituitary and thyroid insufficiency in thalassemic haemosiderosis. Clin Endocrinol 1984; 20: 435-443.
23. Anoussakis CH, Alexious D, Abatzis D, Bechrakis G. Endocrinological investigation of pituitary gonadal axis in thalassemia major. Acta Paediatr Scand 1977; 66: 49-51.
24. Vannasaeng S, Fucharsen S, Pootrakul P, Ploybutr S, Yansukon P. Pituitary function in thalassemic patients and the effect of chelation therapy. Acta Endocrinol 1991; 124: 23-30.
25. Oerter K, Kamp GA, Munson PJ, Nienhuis AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993; 76: 357-361.
26. Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986; 159: 493-498.
27. Chen JC, Hardy PA, Kucharczyk W, Clauberg M, Joshi JG, Vourlas A, Dhar M, Henkelman RM. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. Am J Neuroradiol 1993; 14: 275-281.
28. Dymock IW, Cassar J, Pyke DA, Oakely WG, Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med 1972; 52: 203-210.